Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge

Brasil Notícia Notícia

Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 CNBC
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 72%

The results come amid investor anxiety over the thousands of lawsuits claiming that J&J's talc-based baby powder and other products caused cancer.

Here's how J&J results compared with Wall Street expectations, based on a survey of analysts by Refinitiv:$25.53 billion, vs. $24.62 billion expected

The pharmaceutical giant reported a net income of $5.14 billion, or $1.96 per share. That compares with a net income of $4.8 billion, or $1.80 per share, for theShares of J&J have dropped more than 10% for the year, putting the company's market value at roughly $412 billion. The company raised its 2023 adjusted earnings outlook to $10.70 to $10.80 per share, from a previous forecast of $10.60 to $10.70 per share.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

CNBC /  🏆 12. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Johnson & Johnson sues Biden administration over Medicare drug price negotiationsJohnson & Johnson sues Biden administration over Medicare drug price negotiationsMerck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.
Consulte Mais informação »

Johnson & Johnson joins Merck, others, in fighting Medicare drug-price programJohnson & Johnson joins Merck, others, in fighting Medicare drug-price programJohnson & Johnson has joined companies such as Merck & Co. Inc. Bristol Myers Squibb Co. and other entities in suing the federal government over Medicare’s...
Consulte Mais informação »

Johnson & Johnson must pay $18.8 million to California cancer patient in baby powder suit | CNN BusinessJohnson & Johnson must pay $18.8 million to California cancer patient in baby powder suit | CNN BusinessJohnson & Johnson must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in US bankruptcy court.
Consulte Mais informação »

Johnson & Johnson must pay $18.8 million to California cancer patient in baby powder suitJohnson & Johnson must pay $18.8 million to California cancer patient in baby powder suitJohnson & Johnson must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in US bankruptcy court.
Consulte Mais informação »

Millions could soon have access to life-saving tuberculosis drug following online uproarMillions could soon have access to life-saving tuberculosis drug following online uproarA treatment for multi-drug resistant tuberculosis could soon become more accessible for millions of people worldwide.
Consulte Mais informação »

Comic Slink Johnson Joins the Roast of Houston Hip Hop Notable Trae Tha TruthComic Slink Johnson Joins the Roast of Houston Hip Hop Notable Trae Tha TruthMost know that roast comedy is a fine line between fawning tribute and nasty take-down. But sometimes the best way to show you care for someone is with the perfect hard-hitting joke. Comic Slink Johnson, best known for playing the title role on Adult Swim’s darkly comedic Black Jesus, is...
Consulte Mais informação »



Render Time: 2025-02-25 01:31:26